Sugawara Clinic (Site 3519)

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Familial hypercholesterolaemia2 trials

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Merck Sharp & Dohme LLC2 trials

Running trials

• Active, not recruiting

  Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension

  NCT06492291· Phase 3· Merck Sharp & Dohme LLC· Source

Closed trials

• Completed

  A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids

  NCT05952856· Phase 3· Merck Sharp & Dohme LLC· Source